Antibody-based enzyme-linked lectin assay (ABELLA) for the sialylated recombinant human erythropoietin present in culture supernatant
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hyoung Jin | - |
dc.contributor.author | Lee, Seung Jae | - |
dc.contributor.author | Kim, Hong Jin | - |
dc.date.available | 2019-05-30T04:36:20Z | - |
dc.date.issued | 2008-11 | - |
dc.identifier.issn | 0731-7085 | - |
dc.identifier.issn | 1873-264X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/23556 | - |
dc.description.abstract | The terminal sialic acid of human erythropoietin (hEPO) is essential for in vivo activity. The current resorcinol and HPLC methods for analyzing alpha 2,3-linked sialic acid require more than a microgram of purified rhEPO, and purification takes a great deal of time and labor. In this study, we assessed the use of an antibody-based enzyme-linked lectin assay (ABELLA) for analyzing non-purified recombinant hEPO (rhEPO). The major problem of this method was the high background due to terminal sialylation of components of the assay (antibody and bovine serum albumin) other than rhEPO. To solve this problem, we used a monoclonal antibody (Mab 287) to capture the rhEPO, and oxidized the bovine serum albumin used for blocking with meta-periodate. The sialic acid content of non-purified rhEPO measured by ABELLA was similar to that obtained by the resorcinol method on purified rhEPO. ABELLA has advantages such as adaptability and need for minimal amounts of rhEPO (40 ng/ml). Our observations suggest that ABELLA should reduce the time and labor needed to improve culture conditions so as to increase protein sialylation, and also facilitate the study of sialylation mechanisms. (C) 2008 Published by Elsevier B.V. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.title | Antibody-based enzyme-linked lectin assay (ABELLA) for the sialylated recombinant human erythropoietin present in culture supernatant | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.jpba.2008.07.004 | - |
dc.identifier.bibliographicCitation | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, v.48, no.3, pp 716 - 721 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000260196500029 | - |
dc.identifier.scopusid | 2-s2.0-53049091245 | - |
dc.citation.endPage | 721 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 716 | - |
dc.citation.title | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | - |
dc.citation.volume | 48 | - |
dc.type.docType | Article | - |
dc.publisher.location | 네델란드 | - |
dc.subject.keywordAuthor | Erythropoietin | - |
dc.subject.keywordAuthor | Sialylation | - |
dc.subject.keywordAuthor | Antibody | - |
dc.subject.keywordAuthor | Lectin | - |
dc.subject.keywordPlus | HAMSTER OVARY CELLS | - |
dc.subject.keywordPlus | CHO-CELLS | - |
dc.subject.keywordPlus | N-GLYCOSYLATION | - |
dc.subject.keywordPlus | RICE CELLS | - |
dc.subject.keywordPlus | HETEROGENEITY | - |
dc.subject.keywordPlus | GLYCOPROTEINS | - |
dc.subject.keywordPlus | TEMPERATURE | - |
dc.subject.keywordPlus | BUTYRATE | - |
dc.subject.keywordPlus | AMMONIA | - |
dc.subject.keywordPlus | GROWTH | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Analytical | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.